a
STRUCTURAL HEART DISEASE INITIATIVE
Our senior partners have extensive experience in the cardiovascular industry. Our understanding of structural heart disease (SHD) treatment options and work with physician leaders in cardiac medicine have allowed KCI to establish an international panel of cardiac surgeons, interventional cardiologists and other medical professionals who are participating in first-in-man, clinical trials and device development of emerging transcatheter technologies for treatment of aortic and mitral disease and other structural anomalies. These thought leaders provide KCI with critical insights for future product development, acquisition and marketing activities.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -